Patent · US Active

Method and/or system for closed-loop control of glucose to a treatment range

US10561785B2 · kind B2 · utility

12Cited by
18References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2010
Grant dateFeb 18, 2020
Priority date
Expiry dateMar 28, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2230/201
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, one or more substances may be delivered to a patient at a particular infusion rate while the patient's estimated glucose level is within a predetermined range. A different insulin infusion rate may then be applied if the patient's estimated blood glucose level deviates outside of the predetermined range.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.